Pharmacokinetic and pharmacodynamic characterization of an oral lysophosphatidic acid type 1 receptor-selective antagonist
Swaney, J S, Chapman, C, Correa, L D, Stebbins, K J, Broadhead, A R, Bain, G, Santini, A M, Darlington, J, King, C D, Baccei, C S, Lee, C, Parr, T A, Roppe, J R, Seiders, T J, Ziff, J, Prasit, P, Hutchinson, J H, Evans, J F, Lorrain, D S
Published in The Journal of pharmacology and experimental therapeutics (01.03.2011)
Published in The Journal of pharmacology and experimental therapeutics (01.03.2011)
Get full text
Journal Article
A novel, orally active LPA 1 receptor antagonist inhibits lung fibrosis in the mouse bleomycin model
Swaney, JS, Chapman, C, Correa, LD, Stebbins, KJ, Bundey, RA, Prodanovich, PC, Fagan, P, Baccei, CS, Santini, AM, Hutchinson, JH, Seiders, TJ, Parr, TA, Prasit, P, Evans, JF, Lorrain, DS
Published in British journal of pharmacology (01.08.2010)
Published in British journal of pharmacology (01.08.2010)
Get full text
Journal Article
A novel, orally active LPA(1) receptor antagonist inhibits lung fibrosis in the mouse bleomycin model
Swaney, J. S., Chapman, C., Correa, L. D., Stebbins, K. J., Bundey, R. A., Prodanovich, P. C., Fagan, P., Baccei, C. S., Santini, A. M., Hutchinson, J. H., Seiders, T. J., Parr, T. A., Prasit, P., Evans, J. F., Lorrain, D. S.
Published in British journal of pharmacology (01.08.2010)
Published in British journal of pharmacology (01.08.2010)
Get full text
Journal Article
14 new eclipsing white dwarf plus main-sequence binaries from the SDSS and Catalina surveys
Parsons, S. G., Agurto-Gangas, C., Gänsicke, B. T., Rebassa-Mansergas, A., Schreiber, M. R., Marsh, T. R., Dhillon, V. S., Littlefair, S. P., Drake, A. J., Bours, M. C. P., Breedt, E., Copperwheat, C. M., Hardy, L. K., Buisset, C., Prasit, P., Ren, J. J.
Published in Monthly notices of the Royal Astronomical Society (11.05.2015)
Published in Monthly notices of the Royal Astronomical Society (11.05.2015)
Get full text
Journal Article
Etoricoxib (MK-0663): Preclinical Profile and Comparison with Other Agents That Selectively Inhibit Cyclooxygenase-2
Riendeau, D, Percival, M D, Brideau, C, Charleson, S, Dubé, D, Ethier, D, Falgueyret, J P, Friesen, R W, Gordon, R, Greig, G, Guay, J, Mancini, J, Ouellet, M, Wong, E, Xu, L, Boyce, S, Visco, D, Girard, Y, Prasit, P, Zamboni, R, Rodger, I W, Gresser, M, Ford-Hutchinson, A W, Young, R N, Chan, C C
Published in The Journal of pharmacology and experimental therapeutics (01.02.2001)
Get full text
Published in The Journal of pharmacology and experimental therapeutics (01.02.2001)
Journal Article
A role for oleoylethanolamide in chronic lymphocytic leukemia
Masoodi, M, Lee, E, Eiden, M, Bahlo, A, Shi, Y, Ceddia, R B, Baccei, C, Prasit, P, Spaner, D E
Published in Leukemia (01.07.2014)
Published in Leukemia (01.07.2014)
Get full text
Journal Article
Pharmacodynamics and pharmacokinetics of AM103, a novel inhibitor of 5-lipoxygenase-activating protein (FLAP)
Bain, G, King, C D, Rewolinski, M, Schaab, K, Santini, A M, Shapiro, D, Moran, M, van de Wetering de Rooij, S, Roffel, A F, Schuilenga-Hut, P, Milne, G L, Lorrain, D S, Li, Y, Arruda, J M, Hutchinson, J H, Prasit, P, Evans, J F
Published in Clinical pharmacology and therapeutics (01.04.2010)
Published in Clinical pharmacology and therapeutics (01.04.2010)
Get more information
Journal Article
Rofecoxib [Vioxx, MK-0966; 4-(4â²-Methylsulfonylphenyl)-3-phenyl-2-(5H)-furanone]: A Potent and Orally Active Cyclooxygenase-2 Inhibitor. Pharmacological and Biochemical Profiles
Chan, C C, Boyce, S, Brideau, C, Charleson, S, Cromlish, W, Ethier, D, Evans, J, Ford-Hutchinson, A W, Forrest, M J, Gauthier, J Y, Gordon, R, Gresser, M, Guay, J, Kargman, S, Kennedy, B, Leblanc, Y, Leger, S, Mancini, J, O'Neill, G P, Ouellet, M, Patrick, D, Percival, M D, Perrier, H, Prasit, P, Rodger, I
Published in The Journal of pharmacology and experimental therapeutics (01.08.1999)
Get full text
Published in The Journal of pharmacology and experimental therapeutics (01.08.1999)
Journal Article
A Novel Class of Nonpeptidic Biaryl Inhibitors of Human Cathepsin K
Robichaud, Joël, Oballa, Renata, Prasit, Peppi, Falgueyret, Jean-Pierre, Percival, M. David, Wesolowski, Gregg, Rodan, Sevgi B, Kimmel, Donald, Johnson, Colena, Bryant, Cliff, Venkatraman, Shankar, Setti, Eduardo, Mendonca, Rohan, Palmer, James T
Published in Journal of medicinal chemistry (14.08.2003)
Published in Journal of medicinal chemistry (14.08.2003)
Get full text
Journal Article
Novel, Nonpeptidic Cyanamides as Potent and Reversible Inhibitors of Human Cathepsins K and L
Falgueyret, Jean-Pierre, Oballa, Renata M, Okamoto, Osamu, Wesolowski, Gregg, Aubin, Yves, Rydzewski, Robert M, Prasit, Peppi, Riendeau, Denis, Rodan, Sevgi B, Percival, M. David
Published in Journal of medicinal chemistry (04.01.2001)
Published in Journal of medicinal chemistry (04.01.2001)
Get full text
Journal Article
A novel, orally active LPA1 receptor antagonist inhibits lung fibrosis in the mouse bleomycin model
Swaney, JS, Chapman, C, Correa, LD, Stebbins, KJ, Bundey, RA, Prodanovich, PC, Fagan, P, Baccei, CS, Santini, AM, Hutchinson, JH, Seiders, TJ, Parr, TA, Prasit, P, Evans, JF, Lorrain, DS
Published in British journal of pharmacology (01.08.2010)
Published in British journal of pharmacology (01.08.2010)
Get full text
Journal Article
From indomethacin to a selective COX-2 inhibitor: Development of indolalkanoic acids as potent and selective cyclooxygenase-2 inhibitors
Black, W.C., Bayly, C., Belley, M., Chan, C.-C., Charleson, S., Denis, D., Gauthier, J.Y., Gordon, R., Guay, D., Kargman, S., Lau, C.K., Leblanc, Y., Mancini, J., Ouellet, M., Percival, D., Roy, P., Skorey, K., Tagari, P., Vickers, P., Wong, E., Xu, L., Prasit, P.
Published in Bioorganic & medicinal chemistry letters (19.03.1996)
Published in Bioorganic & medicinal chemistry letters (19.03.1996)
Get full text
Journal Article
New class of potent ligands for the human peripheral cannabinoid receptor
Gallant, Michel, Dufresne, Claude, Gareau, Yves, Guay, Daniel, Leblanc, Yves, Prasit, Petpiboon, Rochette, Chantal, Sawyer, Nicole, Slipetz, Deborah M., Tremblay, Nathalie, Metters, Kathleen M., Labelle, Marc
Published in Bioorganic & medicinal chemistry letters (08.10.1996)
Published in Bioorganic & medicinal chemistry letters (08.10.1996)
Get full text
Journal Article
SAR in the alkoxy lactone series: the discovery of DFP, a potent and orally active COX-2 inhibitor
Leblanc, Y., Roy, P., Boyce, S., Brideau, C., Chan, C.C., Charleson, S., Gordon, R., Grimm, E., Guay, J., Léger, S., Li, C.S., Riendeau, D., Visco, D., Wang, Z., Webb, J., Xu, L.J., Prasit, P.
Published in Bioorganic & medicinal chemistry letters (02.08.1999)
Published in Bioorganic & medicinal chemistry letters (02.08.1999)
Get full text
Journal Article
An efficient synthesis of LTD4 antagonist L-699,392
King, A. O, Corley, E. G, Anderson, R. K, Larsen, R. D, Verhoeven, T. R, Reider, P. J, Xiang, Y. B, Belley, M, Leblanc, Y
Published in Journal of organic chemistry (01.07.1993)
Published in Journal of organic chemistry (01.07.1993)
Get full text
Journal Article
A new series of selective COX-2 inhibitors: 5,6-diarylthiazolo[3,2-b][1,2,4]triazoles
Roy, P., Leblanc, Y., Ball, R.G., Brideau, C., Chan, C.C., Chauret, N., Cromlish, W., Ethier, D., Gauthier, J.Y., Gordon, R., Greig, G., Guay, J., Kargman, S., Lau, C.K., O'Neill, G., Silva, J., Thérien, M., van Staden, C., Wong, E., Xu, L., Prasit, P.
Published in Bioorganic & medicinal chemistry letters (07.01.1997)
Published in Bioorganic & medicinal chemistry letters (07.01.1997)
Get full text
Journal Article
Efficient syntheses of 2-(3′,5′-difluorophenyl)-3-(4′-methylsulfonylphenyl)cyclopent-2-enone, a potent COX-2 inhibitor
Zhao, Dalian, Xu, Feng, Chen, Cheng-yi, Tillyer, Rich D., Grabowski, Edward J.J., Reider, Paul J., Black, Cameron, Ouimet, Nathalie, Prasit, Peppi
Published in Tetrahedron (07.05.1999)
Published in Tetrahedron (07.05.1999)
Get full text
Journal Article
Pharmacology of MK-0591 (3-[1-(4-chlorobenzyl)-3-(t-butylthio)-5-(quinolin-2-yl-methoxy)- indol-2-yl]-2,2-dimethyl propanoic acid), a potent, orally active leukotriene biosynthesis inhibitor
Brideau, C, Chan, C, Charleson, S, Denis, D, Evans, J F, Ford-Hutchinson, A W, Fortin, R, Gillard, J W, Guay, J, Guévremont, D
Published in Canadian journal of physiology and pharmacology (01.06.1992)
Published in Canadian journal of physiology and pharmacology (01.06.1992)
Get more information
Journal Article
5-Lipoxygenase-activating protein is the target of a quinoline class of leukotriene synthesis inhibitors
EVANS, J. F, LEVEILLE, C, LUELL, S, BACH, T. J, MEURER, R, GUAY, J, VICKES, P. J, ROUZER, C. A, GILLARD, J. W, MILLER, D. K, MANCINI, J. A, PRASIT, P, THERIEN, M, ZAMBONI, R, GAUTHIER, J. Y, FORTIN, R, CHARLESSON, P, MACINTYRE, D. E
Published in Molecular pharmacology (01.07.1991)
Get full text
Published in Molecular pharmacology (01.07.1991)
Journal Article